Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2041–2064 of 8,697 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Glaucoma, Macular Pucker, Macula Hole, Vitreomacular Traction, Vitreous Opacities or Hemorrhage
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Pain
Interventions: Ketamine; Procedure
Lead sponsor: Antonios Likourezos; Other
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Platelet Inhibition
Interventions: PN400, ASA, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Colorectal Surgical Procedures
Interventions: Echelon Contour; Device
Lead sponsor: Ethicon Endo-Surgery; Industry
Eligibility: Not listed
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: St Louis, Missouri • Dallas, Texas

Conditions: Respiratory Distress Syndrome, Adult
Interventions: Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells, Plasma-Lyte A; Biological
Lead sponsor: Michael A. Matthay; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 6
States / cities: San Francisco, California • Stanford, California • Boston, Massachusetts + 3 more

Conditions: Kidney Diseases, Kidney Injury, BK Virus Infection, CMV, TTV Virus
Interventions: Blood tests, TRAC( cell free DNA) and T-ID; Diagnostic Test
Lead sponsor: Transplant Genomics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 14
States / cities: Phoenix, Arizona • Los Angeles, California • Kansas City, Kansas + 10 more

Conditions: Hemostasis
Interventions: HEMOBLAST Bellows, Absorbable gelatin sponge, USP with thrombin; Device
Lead sponsor: Biom'Up France SAS; Industry
Eligibility: 21 Years and older
Enrollment: 258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 17
States / cities: Phoenix, Arizona • Los Angeles, California • Pasadena, California + 12 more

Conditions: Porphyria Cutanea Tarda
Interventions: Hydroxychloroquine, Phlebotomy; Drug · Procedure
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 100 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2021
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Soft Tissue Infections
Interventions: Standard care, beta-lactam; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 313 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 8
States / cities: Birmingham, Alabama • Mobile, Alabama • Melbourne, Florida + 4 more

Conditions: Degenerative Disc Disease
Interventions: Avenue® L Interbody Fusion System (LDR Spine); Device
Lead sponsor: LDR Spine USA; Industry
Eligibility: 21 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 4
States / cities: Thornton, Colorado • Atlanta, Georgia • Neptune City, New Jersey + 1 more

Conditions: Complex Partial Seizures
Interventions: vigabatrin; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Kidney Transplant; Complications
Interventions: Extended Release Tacrolimus Tablets, Immediate Release Tacrolimus Capsule; Drug
Lead sponsor: Roy D. Bloom, MD; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Complicated Urinary Tract Infections
Interventions: Eravacycline, Ertapenem, Placebo, Levofloxacin; Drug
Lead sponsor: Tetraphase Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 1,205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 10
States / cities: Fullerton, California • Los Angeles, California • Torrance, California + 7 more

Conditions: Lymphedema, Edema
Interventions: BioBridge® Collagen Matrix, Vascularized Lymph Node Transfer (VLNT); Device · Procedure
Lead sponsor: Fibralign Corporation; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Stanford, California

Conditions: Spinal Anesthesia, Epidural; Anesthesia
Interventions: 10 mg Bupivacaine, 5 mg Bupivacaine; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Head and Neck Cancer, Pancreatic Cancer, Cancer Pancreas
Interventions: [Ga-68]MTP220 PET/CT Scan; Drug
Lead sponsor: Qiubai Li; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Sacroiliac Joint Dysfunction
Interventions: Sacroiliac Joint transfixing and fusion system (Nevro1); Device
Lead sponsor: Nevro Corp; Industry
Eligibility: 21 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 5
States / cities: Lodi, California • Southfield, Michigan • Winston-Salem, North Carolina + 2 more

Conditions: Rectal Adenocarcinoma, Stage I Rectal Cancer AJCC v8, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8, Stage IIB Rectal Cancer AJCC v8, Stage IIC Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8, Stage IV Rectal Cancer AJCC v8, Stage IVA Rectal Cancer AJCC v8, Stage IVB Rectal Cancer AJCC v8, Stage IVC Rectal Cancer AJCC v8
Interventions: Quality-of-Life Assessment, Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 430 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obstructive Sleep Apnea
Interventions: SmartFlex, Standard; Device
Lead sponsor: DeVilbiss Healthcare LLC; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Dallas, Texas • San Antonio, Texas

Conditions: Lung Cancer, Non-small Cell Lung Cancer
Interventions: QOL Questionnaire, Caregiver Satisfaction Questionnaire; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Idiopathic Pulmonary Fibrosis (IPF)
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 35 Years to 80 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV-1 Infection
Interventions: Emtricitabine/rilpivirine/tenofovir disoproxil fumarate; Drug
Lead sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections; Network
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 19
States / cities: Birmingham, Alabama • San Francisco, California • Washington D.C., District of Columbia + 14 more

Conditions: Breast Cancer
Interventions: MOve-ABC, Enhanced Usual Care; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Delayed Graft Function
Interventions: Belatacept, Everolimus; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Search by objective public record fields.

Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study

Ketamine: Comparison of IV Push vs. IV Drip

A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin

A Study of the ECHELON Contour Curved Cutter Stapler Device in Colorectal Procedures

Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)

ID-ENTITY Trial- Evaluating Serial T-ID Monitoring

HEMOBLAST Pivotal Clinical Investigation

Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda

A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Multicenter Study of the Avenue L Interbody Spinal Fusion System Using VerteBRIDGE Plating and Posterior Fixation

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients

Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections

Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)

Bupivacaine With Epidural Volume Extension

[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers

Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

DeVilbiss AutoAdjust With SmartFlex Comparative Study

Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project

Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis

FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir

Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function

Belatacept for Renal Transplant Recipients With Delayed Graft Function